Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warning Letters
Manufacturing
FDA issues Form 483s to Japanese, Indian drugmakers
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered a variety of problems.
Joseph Keenan
Sep 10, 2024 8:50am
EyePoint's Yutiq production lands in the FDA's crosshairs
Aug 27, 2024 4:07pm
FDA rebukes troubled Eugia production site with a warning letter
Aug 19, 2024 8:10am
CDMO Brassica blasted in 4-observation FDA warning letter
Jul 24, 2024 9:25am
FDA slams Dr. Reddy's plants in India with a pair of Form 483s
Jun 25, 2024 8:10am
FDA slams Chinese API maker Sichuan Deebio with warning letter
Feb 22, 2024 9:10am
